ANAB Anaptysbio Inc

Price (delayed)

$26.11

Market cap

$714.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.71

Enterprise value

$504.84M

Sector: Healthcare
Industry: Biotechnology

Highlights

ANAB's debt has plunged by 100% YoY
ANAB's EPS is up by 23% year-on-year and by 9% since the previous quarter
The company's quick ratio fell by 26% QoQ and by 2.3% YoY
Anaptysbio's equity has decreased by 14% YoY and by 6% from the previous quarter

Key stats

What are the main financial stats of ANAB
Market
Shares outstanding
27.35M
Market cap
$714.05M
Enterprise value
$504.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.98
Price to sales (P/S)
39.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
28.05
Earnings
Revenue
$18M
EBIT
-$73.66M
EBITDA
-$73.11M
Free cash flow
-$67.9M
Per share
EPS
-$2.71
Free cash flow per share
-$2.49
Book value per share
$13.19
Revenue per share
$0.66
TBVPS
$14.09
Balance sheet
Total assets
$384.75M
Total liabilities
$24.51M
Debt
$0
Equity
$360.24M
Working capital
$321.34M
Liquidity
Debt to equity
0
Current ratio
14.13
Quick ratio
13.83
Net debt/EBITDA
2.86
Margins
EBITDA margin
-406.2%
Gross margin
100%
Net margin
-410.2%
Operating margin
-441.6%
Efficiency
Return on assets
-17.9%
Return on equity
-19.1%
Return on invested capital
-37.6%
Return on capital employed
-20.4%
Return on sales
-409.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANAB stock price

How has the Anaptysbio stock price performed over time
Intraday
1.87%
1 week
3.04%
1 month
6.66%
1 year
68.34%
YTD
21.44%
QTD
21.44%

Financial performance

How have Anaptysbio's revenue and profit performed over time
Revenue
$18M
Gross profit
$18M
Operating income
-$79.48M
Net income
-$73.84M
Gross margin
100%
Net margin
-410.2%
The company's operating margin has surged by 79% YoY and by 11% QoQ
ANAB's net margin has soared by 78% YoY and by 9% from the previous quarter
ANAB's operating income is up by 24% year-on-year and by 11% since the previous quarter
The net income has increased by 22% YoY and by 9% QoQ

Growth

What is Anaptysbio's growth rate over time

Valuation

What is Anaptysbio stock price valuation
P/E
N/A
P/B
1.98
P/S
39.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
28.05
ANAB's EPS is up by 23% year-on-year and by 9% since the previous quarter
ANAB's P/B is 65% higher than its last 4 quarters average of 1.2
Anaptysbio's equity has decreased by 14% YoY and by 6% from the previous quarter
The stock's price to sales (P/S) is 24% more than its last 4 quarters average of 32.0

Efficiency

How efficient is Anaptysbio business performance
ANAB's return on sales has surged by 78% year-on-year and by 9% since the previous quarter
The return on invested capital has declined by 31% year-on-year
The ROA has increased by 8% YoY and by 5% QoQ
Anaptysbio's return on equity has increased by 7% YoY and by 5% QoQ

Dividends

What is ANAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANAB.

Financial health

How did Anaptysbio financials performed over time
The company's quick ratio fell by 26% QoQ and by 2.3% YoY
The company's total liabilities rose by 21% QoQ but it fell by 20% YoY
ANAB's debt is 100% less than its equity
Anaptysbio's equity has decreased by 14% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.